SpectraCure AB engages in the research, development, and provision of equipment for cancer treatments. It focuses on cancer treatments using medical systems with laser light sources and reactive drugs, which are referred to as interstitial photodynamic therapy. The company was founded by Sune Roland Svanberg, Katarina Svanberg, and Stefan Andersson-Engels in March 2003 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company